191 related articles for article (PubMed ID: 28540892)
1. Aldosterone synthase gene is not a major susceptibility gene for progression of chronic kidney disease in patients with autosomal dominant polycystic kidney disease.
Ramanathan G; Elumalai R; Periyasamy S; Lakkakula BVKS
Saudi J Kidney Dis Transpl; 2017; 28(3):552-557. PubMed ID: 28540892
[TBL] [Abstract][Full Text] [Related]
2. NOS3 tagSNPs does not modify the chronic kidney disease progression in autosomal dominant polycystic kidney disease.
Ramanathan G; Periyasamy S; Lakkakula BV
Nephrology (Carlton); 2014 Sep; 19(9):537-41. PubMed ID: 24824375
[TBL] [Abstract][Full Text] [Related]
3. Angiotensinogen gene polymorphisms and progression of chronic kidney disease in ADPKD patients.
Gnanasambandan R; Elumalai R; Soundararajan P; Lakkakula BVKS
Clin Exp Nephrol; 2016 Aug; 20(4):561-568. PubMed ID: 26482465
[TBL] [Abstract][Full Text] [Related]
4. Influence of angiotensin converting enzyme (
Ramanathan G; Ghosh S; Elumalai R; Periyasamy S; Lakkakula BV
Indian J Med Res; 2016 Jun; 143(6):748-755. PubMed ID: 27748299
[TBL] [Abstract][Full Text] [Related]
5. Renin gene rs1464816 polymorphism contributes to chronic kidney disease progression in ADPKD.
Ramanathan G; Elumalai R; Periyasamy S; Lakkakula BV
J Biomed Sci; 2016 Jan; 23():1. PubMed ID: 26753721
[TBL] [Abstract][Full Text] [Related]
6. Endothelin 1 gene is not a major modifier of chronic kidney disease advancement among the autosomal dominant polycystic kidney disease patients.
Annapareddy SN; Elumalai R; Lakkakula BV; Ramanathan G; Periyasamy S
J Nephropharmacol; 2016; 5(1):13-18. PubMed ID: 28197493
[No Abstract] [Full Text] [Related]
7. Role of renin-angiotensin-aldosterone system gene polymorphisms and hypertension-induced end-stage renal disease in autosomal dominant polycystic kidney disease.
Ramanathan G; Elumalai R; Periyasamy S; Lakkakula B
Iran J Kidney Dis; 2014 Jul; 8(4):265-77. PubMed ID: 25001132
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin-aldosterone system related gene polymorphisms and urinary total arsenic is related to chronic kidney disease.
Chen WJ; Huang YL; Shiue HS; Chen TW; Lin YF; Huang CY; Lin YC; Han BC; Hsueh YM
Toxicol Appl Pharmacol; 2014 Sep; 279(2):95-102. PubMed ID: 24907556
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone Synthase CYP11B2 Gene Promoter Polymorphism in a Turkish Population With Chronic Kidney Disease.
Yilmaz M; Sari I; Bagci B; Gumus E; Ozdemir O
Iran J Kidney Dis; 2015 May; 9(3):209-14. PubMed ID: 25957425
[TBL] [Abstract][Full Text] [Related]
10. Dysmetabolic markers predict outcomes in autosomal dominant polycystic kidney disease.
Kocyigit I; Ozturk F; Eroglu E; Karaca Z; Kaynar AS; Cetin M; Tokgoz B; Sipahioglu MH; Bayramov R; Sen A; Oymak O; Ecder T; Axelsson J
Clin Exp Nephrol; 2019 Sep; 23(9):1130-1140. PubMed ID: 31134465
[TBL] [Abstract][Full Text] [Related]
11. Association of the ACE gene polymorphism with the progression of autosomal dominant polycystic kidney disease.
Lee KB; Kim UK; Lee CC
J Korean Med Sci; 2000 Aug; 15(4):431-5. PubMed ID: 10983692
[TBL] [Abstract][Full Text] [Related]
12. The association of endothelin-1 levels with renal survival in polycystic kidney disease patients.
Kocyigit I; Eroglu E; Kaynar AS; Kocer D; Kargi S; Zararsiz G; Bayramov R; Imamoglu H; Sipahioglu MH; Tokgoz B; Dundar M; Oymak O
J Nephrol; 2019 Feb; 32(1):83-91. PubMed ID: 30022320
[TBL] [Abstract][Full Text] [Related]
13. The cytochrome 11B2 aldosterone synthase gene rs1799998 single nucleotide polymorphism determines elevated aldosterone, higher blood pressure, and reduced glomerular filtration, especially in diabetic female patients.
Sydorchuk L; Dzhuryak V; Sydorchuk A; Levytska S; Petrynych V; Knut R; Kshanovska A; Iftoda O; Tkachuk O; Kyfiak P; Popovich A; Khomko O; Sydorchuk R
Endocr Regul; 2020 Jul; 54(3):217-226. PubMed ID: 32857720
[TBL] [Abstract][Full Text] [Related]
14. Angiotensinogen and angiotensin II type 1 receptor gene polymorphism in patients with autosomal dominant polycystic kidney disease: effect on hypertension and ESRD.
Lee KB; Kim UK
Yonsei Med J; 2003 Aug; 44(4):641-7. PubMed ID: 12950120
[TBL] [Abstract][Full Text] [Related]
15. Association of the human CYP11B2 gene and essential hypertension in southwest Han Chinese population: a haplotype-based case-control study.
Chen B; Nie S; Luo S; Zhang W; Xiao C
Clin Exp Hypertens; 2011; 33(2):106-12. PubMed ID: 21269059
[TBL] [Abstract][Full Text] [Related]
16. Hospital-based inpatient resource utilization associated with autosomal dominant polycystic kidney disease in the US.
Blanchette CM; Craver C; Belk KW; Lubeck DP; Rossetti S; Gutierrez B
J Med Econ; 2015 Apr; 18(4):303-11. PubMed ID: 25372357
[TBL] [Abstract][Full Text] [Related]
17. Association between Aldosterone Synthase (
Shah WA; Jan A; Khan MA; Saeed M; Rahman N; Zakiullah ; Afridi MS; Khuda F; Akbar R
Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372364
[TBL] [Abstract][Full Text] [Related]
18. Haplotype association and synergistic effect of human aldosterone synthase (CYP11B2) gene polymorphisms causing susceptibility to essential hypertension in Indian patients.
Vamsi UM; Swapna N; Padma G; Vishnupriya S; Padma T
Clin Exp Hypertens; 2016; 38(8):659-665. PubMed ID: 27935319
[TBL] [Abstract][Full Text] [Related]
19. A novel haplotype of low-frequency variants in the aldosterone synthase gene among northern Han Chinese with essential hypertension.
Zhang H; Li X; Zhou L; Zhang K; Zhang Q; Li J; Wang N; Jin M; Wu N; Cong M; Qiu C
Medicine (Baltimore); 2017 Sep; 96(39):e8150. PubMed ID: 28953657
[TBL] [Abstract][Full Text] [Related]
20. Modulation of aldosterone levels by aldosterone synthase promoter polymorphism and association with eGFR decline in patients with chronic kidney disease.
Qian J; Zhong J; Yan M; Shi H; Hao C; Gu Y; Lai L
Discov Med; 2018 Dec; 26(145):251-260. PubMed ID: 30695674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
